VE (nerve agent)
Chemical compound and nerve agent

VE is a nerve agent of the V-series of organophosphorus compounds. It is closely related to the more well-known VX nerve agent. Like other V-series agents, VE is a potent acetylcholinesterase inhibitor, leading to the accumulation of acetylcholine in the synaptic cleft and causing continuous stimulation of muscles, glands, and central nervous system.
Chemical properties
VE is an organophosphate compound with the chemical formula C11H26NO2PS. It is a colorless to amber-colored liquid at room temperature. The compound is odorless and tasteless, making it difficult to detect without specialized equipment.
Mechanism of action
VE acts by inhibiting the enzyme acetylcholinesterase, which is responsible for breaking down the neurotransmitter acetylcholine in the synaptic cleft. When acetylcholinesterase is inhibited, acetylcholine accumulates, leading to continuous stimulation of muscles and nerves. This results in muscle paralysis, respiratory failure, and potentially death if not treated promptly.
Toxicity and symptoms
Exposure to VE can occur through inhalation, ingestion, or skin contact. Symptoms of exposure include miosis (constricted pupils), rhinorrhea (runny nose), dyspnea (difficulty breathing), muscle twitching, and convulsions. Severe exposure can lead to coma and death.
Treatment
The primary treatment for VE exposure is the administration of atropine and pralidoxime. Atropine works by blocking the effects of acetylcholine at muscarinic receptors, while pralidoxime reactivates acetylcholinesterase. Diazepam may also be used to control seizures.
History and development
The V-series nerve agents, including VE, were developed in the 1950s by the United Kingdom and later by the United States and other countries. These agents were designed to be more persistent and potent than earlier nerve agents like sarin and tabun.
Related pages
References
- Frederick R.,
Medical Aspects of Chemical and Biological Warfare, Office of The Surgeon General, Department of the Army, United States of America, 1997, ISBN 978-0-16-045135-3,
- Emsley, John,
The Shocking History of Phosphorus, Nature, 1998, Vol. 393(Issue: 6682), pp. 127–128, DOI: 10.1038/30164,
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian